ReviewJournal of clinical pharmacy and therapeutics2020

Managing the multifaceted nature of type 2 diabetes using once-weekly injectable GLP-1 receptor agonist therapy.

Andrew BzowyckyjPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.